Jubilant Pharmo Consolidated December 2022 Net Sales at Rs 1,552.51 crore, up 18.46% Y-o-Y
February 04, 2023 / 00:52 IST
Reported Consolidated quarterly numbers for Jubilant Pharmova are:Net Sales at Rs 1,552.51 crore in December 2022 up 18.46% from Rs. 1,310.53 crore in December 2021.
Quarterly Net Loss at Rs. 15.67 crore in December 2022 down 130.73% from Rs. 50.99 crore in December 2021.
EBITDA stands at Rs. 155.35 crore in December 2022 down 22.38% from Rs. 200.15 crore in December 2021.
| Jubilant Pharmo shares closed at 348.10 on February 02, 2023 (NSE) and has given 0.01% returns over the last 6 months and -33.61% over the last 12 months. |
| Jubilant Pharmova | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'22 | Sep'22 | Dec'21 | | Net Sales/Income from operations | 1,552.51 | 1,584.74 | 1,297.60 | | Other Operating Income | -- | 14.76 | 12.93 | | Total Income From Operations | 1,552.51 | 1,599.50 | 1,310.53 | | EXPENDITURE | | Consumption of Raw Materials | 410.32 | 439.61 | 282.17 | | Purchase of Traded Goods | 81.34 | 62.47 | 54.63 | | Increase/Decrease in Stocks | -13.59 | -18.98 | -63.39 | | Power & Fuel | -- | -- | -- | | Employees Cost | 567.94 | 534.60 | 524.54 | | Depreciation | 94.28 | 93.95 | 93.33 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 360.62 | 363.05 | 318.34 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 51.60 | 124.80 | 100.91 | | Other Income | 9.47 | 13.10 | 5.91 | | P/L Before Int., Excpt. Items & Tax | 61.07 | 137.90 | 106.82 | | Interest | 50.69 | 42.02 | 36.62 | | P/L Before Exceptional Items & Tax | 10.38 | 95.88 | 70.20 | | Exceptional Items | -- | -56.82 | -- | | P/L Before Tax | 10.38 | 39.06 | 70.20 | | Tax | 24.77 | 31.48 | 19.43 | | P/L After Tax from Ordinary Activities | -14.39 | 7.58 | 50.77 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -14.39 | 7.58 | 50.77 | | Minority Interest | 0.37 | 0.57 | 0.19 | | Share Of P/L Of Associates | -1.65 | -2.66 | 0.03 | | Net P/L After M.I & Associates | -15.67 | 5.49 | 50.99 | | Equity Share Capital | 15.91 | 15.92 | 15.92 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.98 | 0.34 | 3.20 | | Diluted EPS | -0.98 | 0.34 | 3.20 | | EPS After Extra Ordinary | | Basic EPS | -0.98 | 0.48 | 3.20 | | Diluted EPS | -0.98 | 0.34 | 3.20 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
